JP2015516419A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015516419A5 JP2015516419A5 JP2015511518A JP2015511518A JP2015516419A5 JP 2015516419 A5 JP2015516419 A5 JP 2015516419A5 JP 2015511518 A JP2015511518 A JP 2015511518A JP 2015511518 A JP2015511518 A JP 2015511518A JP 2015516419 A5 JP2015516419 A5 JP 2015516419A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- diabetes
- treatment
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261645101P | 2012-05-10 | 2012-05-10 | |
| US61/645,101 | 2012-05-10 | ||
| US201361769221P | 2013-02-26 | 2013-02-26 | |
| US61/769,221 | 2013-02-26 | ||
| PCT/US2013/039164 WO2013169546A1 (en) | 2012-05-10 | 2013-05-02 | Pyrazole compounds as sglt1 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015516419A JP2015516419A (ja) | 2015-06-11 |
| JP2015516419A5 true JP2015516419A5 (enExample) | 2016-06-16 |
| JP6148725B2 JP6148725B2 (ja) | 2017-06-14 |
Family
ID=48428684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511518A Active JP6148725B2 (ja) | 2012-05-10 | 2013-05-02 | Ｓｇｌｔ１阻害剤としてのピラゾール化合物 |
Country Status (42)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA113086C2 (xx) * | 2012-05-10 | 2016-12-12 | Піразольні сполуки як інгібітори sglt1 | |
| TW201425326A (zh) | 2012-10-05 | 2014-07-01 | Lilly Co Eli | 新穎脲化合物 |
| AR097890A1 (es) | 2013-10-17 | 2016-04-20 | Lilly Co Eli | Compuestos de urea |
| AR098134A1 (es) | 2013-11-01 | 2016-05-04 | Lilly Co Eli | Compuestos de urea |
| AR098670A1 (es) * | 2013-11-08 | 2016-06-08 | Lilly Co Eli | Inhibidor de sglt1 |
| CN110054657B (zh) * | 2018-01-18 | 2021-06-29 | 亚宝药业集团股份有限公司 | 吡喃葡萄糖取代的吡唑化合物及其制备方法 |
| MX2020010433A (es) * | 2018-04-04 | 2020-10-28 | Japan Tobacco Inc | Compuestos de pirazol sustituidos con heteroarilo y uso farmaceutico de los mismos. |
| AU2020341926B2 (en) * | 2019-09-04 | 2026-02-26 | Shionogi & Co., Ltd. | Therapeutic or prophylactic method for diabetes using combination medicine |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0013667B8 (pt) | 1999-08-31 | 2021-05-25 | Kissei Pharmaceutical | derivados de glucopiranosiloxipirazol, composições medicinais contendo os mesmos e seus intermediários na produção deles |
| WO2002068439A1 (fr) | 2001-02-26 | 2002-09-06 | Kissei Pharmaceutical Co., Ltd. | Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci |
| EP1400529A4 (en) | 2001-05-30 | 2007-12-19 | Kissei Pharmaceutical | GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF |
| BRPI0313290B1 (pt) | 2002-08-08 | 2016-12-06 | Kissei Pharmaceutical | derivados de pirazol, promedicamento, composição farmacêutica, agentes terapêuticos e uso medicinal |
| JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
| DE102004028241B4 (de) * | 2004-06-11 | 2007-09-13 | Sanofi-Aventis Deutschland Gmbh | Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel |
| AR061026A1 (es) * | 2006-05-19 | 2008-07-30 | Taisho Pharmaceutical Co Ltd | Compuesto glicitol c-fenilo y preparacion farmaceutica |
| CA2709530C (en) | 2007-12-27 | 2016-02-23 | Kissei Pharmaceutical Co., Ltd. | Monosebacate of pyrazole derivative |
| MY155658A (en) | 2009-02-23 | 2015-11-13 | Taisho Pharmaceutical Co Ltd | A-isopropylphenyl glucitol compounds as sglti inhibitors |
| WO2011039338A2 (en) | 2009-10-02 | 2011-04-07 | Sanofi-Aventis | Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases |
| US8163704B2 (en) | 2009-10-20 | 2012-04-24 | Novartis Ag | Glycoside derivatives and uses thereof |
| UA113086C2 (xx) * | 2012-05-10 | 2016-12-12 | Піразольні сполуки як інгібітори sglt1 |
-
2013
- 2013-02-05 UA UAA201412088A patent/UA113086C2/uk unknown
- 2013-04-23 JO JOP/2013/0117A patent/JO3136B1/ar active
- 2013-04-23 AR ARP130101348A patent/AR090806A1/es active IP Right Grant
- 2013-04-25 TW TW102114877A patent/TWI579295B/zh active
- 2013-05-02 ES ES13722231.1T patent/ES2588835T3/es active Active
- 2013-05-02 US US13/875,314 patent/US8697849B2/en active Active
- 2013-05-02 SG SG11201407345QA patent/SG11201407345QA/en unknown
- 2013-05-02 PE PE2014001716A patent/PE20142399A1/es active IP Right Grant
- 2013-05-02 CA CA2869323A patent/CA2869323C/en active Active
- 2013-05-02 EA EA201491852A patent/EA024207B1/ru not_active IP Right Cessation
- 2013-05-02 KR KR1020147031119A patent/KR101685779B1/ko active Active
- 2013-05-02 WO PCT/US2013/039164 patent/WO2013169546A1/en not_active Ceased
- 2013-05-02 NZ NZ700356A patent/NZ700356A/en unknown
- 2013-05-02 ME MEP-2016-121A patent/ME02405B/me unknown
- 2013-05-02 HU HUE13722231A patent/HUE030414T2/en unknown
- 2013-05-02 MX MX2014013615A patent/MX357058B/es active IP Right Grant
- 2013-05-02 AP AP2014008044A patent/AP3593A/xx active
- 2013-05-02 PL PL13722231T patent/PL2850084T3/pl unknown
- 2013-05-02 LT LTEP13722231.1T patent/LT2850084T/lt unknown
- 2013-05-02 HR HRP20160804TT patent/HRP20160804T1/hr unknown
- 2013-05-02 JP JP2015511518A patent/JP6148725B2/ja active Active
- 2013-05-02 IN IN7996DEN2014 patent/IN2014DN07996A/en unknown
- 2013-05-02 BR BR112014026198-9A patent/BR112014026198B1/pt active IP Right Grant
- 2013-05-02 MY MYPI2014703279A patent/MY177326A/en unknown
- 2013-05-02 AU AU2013259946A patent/AU2013259946B2/en active Active
- 2013-05-02 SI SI201330209A patent/SI2850084T1/sl unknown
- 2013-05-02 RS RS20160626A patent/RS55107B1/sr unknown
- 2013-05-02 EP EP13722231.1A patent/EP2850084B1/en active Active
- 2013-05-02 PT PT137222311T patent/PT2850084T/pt unknown
- 2013-05-02 DK DK13722231.1T patent/DK2850084T3/en active
-
2014
- 2014-02-18 US US14/182,354 patent/US9296775B2/en active Active
- 2014-09-30 TN TNP2014000410A patent/TN2014000410A1/fr unknown
- 2014-10-10 CR CR20140473A patent/CR20140473A/es unknown
- 2014-10-16 ZA ZA2014/07531A patent/ZA201407531B/en unknown
- 2014-10-22 CL CL2014002845A patent/CL2014002845A1/es unknown
- 2014-10-30 IL IL235427A patent/IL235427A/en active IP Right Grant
- 2014-11-03 DO DO2014000250A patent/DOP2014000250A/es unknown
- 2014-11-05 GT GT201400242A patent/GT201400242A/es unknown
- 2014-11-05 MA MA37501A patent/MA37501B1/fr unknown
- 2014-11-07 EC ECIEPI201426088A patent/ECSP14026088A/es unknown
- 2014-11-07 PH PH12014502492A patent/PH12014502492A1/en unknown
- 2014-11-11 CO CO14249415A patent/CO7141429A2/es unknown
-
2016
- 2016-08-11 CY CY20161100801T patent/CY1117912T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015516419A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2013509429A5 (enExample) | ||
| JP2013525444A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| JP2016508134A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| JP2017537066A5 (enExample) | ||
| JP2013542247A5 (enExample) | ||
| JP2012532874A5 (enExample) | ||
| JP2011102304A5 (enExample) | ||
| JP2014507446A5 (enExample) | ||
| JP2014521735A5 (enExample) | ||
| JP2013519675A5 (enExample) | ||
| JP2017524735A5 (enExample) | ||
| JP2013014622A5 (enExample) | ||
| JP2015078230A5 (enExample) | ||
| JP2016515561A5 (enExample) | ||
| ME02841B (me) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| EA201490419A1 (ru) | Соединения для лечения и профилактики респираторного синцитиального вирусного заболевания | |
| JP2016518337A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| JP2014507477A5 (enExample) | ||
| JP2015193630A5 (enExample) | ||
| JP2016522254A5 (enExample) |